格隆匯4月7日丨花園生物(300401.SZ)于近期投資者關系活動表示,公司將進入維生素D3產業鏈終端原料藥及制劑領域。
特別聲明:以上內容(如有圖片或視頻亦包括在內)為自媒體平臺“網易號”用戶上傳并發布,本平臺僅提供信息存儲服務。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.